Detection kit for completely homogeneous determination of Brucella antibody and application thereof

Through a detection kit for fully homogeneous determination of brucella antibodies, the antigens marked by acridinyl ester and horseradish peroxidase are solved by combining antioxidants and other components, and the problems of cumbersome operation and insufficient sensitivity in the prior art are solved. , achieves rapid and accurate brucellosis detection, suitable for large-scale screening needs in endemic areas.

CN118962133AInactive Publication Date: 2024-11-15深圳市绿诗源生物技术有限公司
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411399500.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing brucellosis detection methods have problems such as cumbersome operation, time-consuming, insufficient sensitivity and specificity, especially false positive reactions to cross-reacting bacterial infection patients and vaccinated animals, and the operators have high professional requirements, which makes it difficult to Meet the needs of large-scale screening in endemic areas.

Method used

Using a detection kit for the complete homogeneous determination of brucellosis antibodies, including liquids A and B, brucellosis antigens labeled with acridinyl ester and horseradish peroxidase labeled brucellosis antigens, combined with phosphoric acid Salt buffer, antioxidants and other components can achieve rapid and sensitive detection through spatial proximity chemiluminescence technology.

Benefits of technology

It significantly shortens the detection time to 15 minutes, improves the sensitivity and accuracy of the detection, reduces operating steps and waste emissions, reduces detection costs, and achieves high-accuracy results, suitable for large-scale screening in popular areas.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118962133A_ABST
    Figure CN118962133A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of biological detection, and discloses a detection kit for complete homogeneous determination of a Brucella antibody and application of the detection kit. The detection kit comprises a calibration product, a quality control product, a solution A and a solution B, wherein the solution A comprises an acridinium ester-labeled Brucella antigen and a horseradish peroxidase-labeled Brucella antigen; the Brucella antigen is from cattle or sheep; and the solution B comprises p-hydroxycinnamic acid, hydrogen peroxide, urea peroxide and PC 300. The detection kit significantly improves the simplicity, sensitivity, specificity and repeatability of detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of biological detection, and in particular to a detection kit for completely homogeneously detecting Brucella antibodies and an application thereof. Background Art

[0002] Brucellosis (hereinafter referred to as brucellosis) is a zoonotic infectious disease caused by infection with Brucella bacteria. It seriously affects public health and the healthy development of animal husbandry worldwide. Brucella infection in humans has been reported in more than 170 countries. Human infection mainly comes from sick animals and their products. Therefore, the purification of brucellosis among animals is crucial to the control of human brucellosis, and comprehensive prevention and control of brucellosis from the animal source is imperative. At present, my country has listed brucellosis as a notifiable animal disease and has carried out brucellosis prevention and control work nationwide. Accurate diagnostic methods are an important part of brucellosis prevention and control.

[0003] Compared with culture and PCR methods, serological methods are relatively economical and simple, and are more suitable for large-scale screening in epidemic areas. The serological diagnostic methods for brucellosis recommended by the national standard "Diagnostic Technology for Animal Brucellosis" (GB / T18646-2018) and the World Organization for Animal Health (WOAH) mainly include red tiger plate agglutination test (RBT), tube agglutination test (SAT), complement fixation test (CFT) and enzyme-linked immunosorbent assay (ELISA). However, these methods also have their own advantages and disadvantages. For example, SAT and CFT are time-consuming, cumbersome, and the result judgment is very dependent on the experience of professional technicians; although RBT is simple to operate and can get results within a few minutes, its high sensitivity will produce false positives in vaccinated animals and false positive reactions in patients with cross-reactive bacterial infections; although ELISA has high specificity and sensitivity, the test process requires multiple washing and incubations, which has high professional requirements for operators and takes a long time. Therefore, it is urgent to develop a brucellosis detection method that is simple to operate, faster in reaction, and has high sensitivity, specificity, and accuracy. Summary of the invention

[0004] In view of the defects in the prior art, the present invention provides a detection kit for completely homogeneously determining Brucella antibodies and its application.

[0005] The present invention provides a detection kit for completely homogeneously determining Brucella antibodies, comprising liquid A, liquid B, a calibrator, and a quality control product. The kit also comprises a sample solution to be tested provided by a user.

[0006] Furthermore, the A solution includes Brucella antigens labeled with acridinium ester and Brucella antigens labeled with horseradish peroxidase.

[0007] Furthermore, the Brucella antigen is from cattle or sheep.

[0008] Furthermore, the A solution also includes one or more of phosphate buffer, Tris-HCl solution, arginine, bovine serum albumin, sodium thiosulfate, trehalose, sucrose, mannitol, disodium ethylenediaminetetraacetic acid, PEG 20000, Tween-20, EC oxidase, enzyme stabilizer, glycerol, ascorbic acid, uric acid, tea polyphenols, glutathione, thioredoxin, lysine, PC 300, and PC 150.

[0009] Preferably, the A solution comprises bovine serum albumin, Tris-HCl solution, Tween-20, lysine, PC 300, ascorbic acid, acridinium ester-labeled Brucella antigen, and horseradish peroxidase-labeled Brucella antigen. Furthermore, the liquid B includes one or more of p-hydroxycinnamic acid, hydrogen peroxide, urea peroxide, and PC 300.

[0010] Preferably, the B solution includes hydrogen peroxide and PC 300.

[0011] Furthermore, the calibrator is a Brucella high immunity serum dilution, and the concentration of the Brucella high immunity serum dilution is 0~500 IU / mL.

[0012] Preferably, the concentration of the Brucella high immune serum dilution is 0 IU / mL, 5 IU / mL, 10 IU / mL, 50 IU / mL, 100 IU / mL, and 500 IU / mL.

[0013] Furthermore, the quality control product is Brucella high immunity serum dilution, and the concentration of the Brucella high immunity serum dilution is 0~200 IU / mL.

[0014] Preferably, the concentration of the Brucella high immune serum dilution is 0 IU / mL and 200 IU / mL.

[0015] Furthermore, the volume ratio of liquid A to liquid B is (0.6~1):1.

[0016] Preferably, the volume ratio of the liquid A to the liquid B is 3:5. The volume ratio of the sample liquid to be tested provided in the embodiment of the present invention to the liquid A and the liquid B is (1-5): (1-5): (5-10), preferably 1:3:5; wherein the sample to be tested is any one of 1 μL, 2 μL, 3 μL, 4 μL, and 5 μL, the liquid A is any one of 6 μL, 9 μL, 12 μL, 15 μL, 18 μL, 21 μL, and 24 μL, and the liquid B is any one of 5 μL, 10 μL, 15 μL, 20 μL, 25 μL, 35 μL, 45 μL, and 50 μL.

[0017] The present invention also provides the use of the detection kit in detecting Brucella antibodies for non-disease diagnosis purposes.

[0018] Furthermore, the Brucella antibody is from cattle or sheep.

[0019] In summary, compared with the prior art, the present invention achieves the following technical effects: 1. The kit of the present invention adopts a completely homogeneous detection, which is the closest to the natural state of the body, and has the characteristics of being simple, rapid, and having a wide range of detection. The completely homogeneous system is more conducive to the reaction of antigen and antibody, and the reaction time can be shortened to within 15 minutes, significantly improving the detection speed; at the same time, the system can improve the utilization rate of antigens, thereby improving the sensitivity and accuracy of detection.

[0020] 2. The present invention adds an antioxidant to liquid A, which can quickly remove free radicals or other interfering substances in the sample, effectively control the background, and improve the sensitivity of the kit.

[0021] 3. The kit of the present invention does not require coating or washing, which effectively controls operation time and cost, reduces waste discharge, and is more convenient for clinical use.

[0022] 4. The minimum detection limit of the kit described in the present invention corresponds to a concentration of 1 IU / mL, and the accuracy is extremely high. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.

[0024] Figure 1 It is the calibration curve diagram of Example 7 of the present invention, wherein the Y axis is the Brucella antibody concentration and the X axis is the peak area; Figure 2 This is a correlation analysis diagram of the test results of samples of known concentrations in Example 8 of the present invention, wherein the X-axis represents the concentration value measured by the kit and the Y-axis represents the known concentration value. DETAILED DESCRIPTION

[0025] In order to enable those skilled in the art to better understand the scheme of the present invention, the technical scheme in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only embodiments of a part of the present invention, not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without making creative work should fall within the scope of protection of the present invention.

[0026] If no specific techniques or conditions are specified in the examples of the present invention, all are carried out according to the techniques or conditions described in the literature in the field or according to the product instructions. If no manufacturer is specified for the reagents or instruments used, all are conventional products that can be obtained through commercial purchase or other channels.

[0027] In the present invention, BSA represents bovine serum albumin; PBS represents phosphate buffered saline; PC 300 represents antibacterial preservative proclin 300; HRP represents horseradish peroxidase; and Tris-HCl represents tris-hydroxymethylaminomethane hydrochloride.

[0028] The kit of the present invention realizes the purpose of completely homogeneously detecting Brucella antibodies based on spatial proximity chemiluminescence technology, thereby improving the sensitivity and accuracy of detection. The kit comprises liquid A, liquid B, calibrators, and quality control products; The A solution includes a buffer, a stabilizer, an antioxidant, and a preservative; the buffer includes but is not limited to the Tris-HCl solution of the embodiment of the present invention, and simply replacing the Tris-HCl solution with a phosphate buffer also falls within the protection scope of the present invention; The stabilizer includes but is not limited to the bovine serum albumin of the embodiment of the present invention. By simply replacing the bovine serum albumin with sodium thiosulfate, trehalose, sucrose, mannitol, disodium ethylenediaminetetraacetate, PEG 20000, Tween-20, EC oxidase, enzyme stabilizer, glycerol, arginine, lysine, it also belongs to the protection scope of the present invention; The antioxidant includes but is not limited to the ascorbic acid of the embodiment of the present invention. Simply replacing ascorbic acid with uric acid, tea polyphenols, glutathione, and thioredoxin also falls within the protection scope of the present invention. The preservatives include PC 300 and PC150; the B liquid includes an activator, which includes but is not limited to the hydrogen peroxide in the embodiment of the present invention. Simply replacing the hydrogen peroxide with p-hydroxycinnamic acid or urea peroxide also falls within the protection scope of the present invention; the B liquid also includes PC 300.

[0029] Example 1 Preparation of Calibrators and Quality Control Products 1. Preparation of original Brucella high immune serum Preparation method of high concentration serum of Brucella antibody Brucella antibody-negative sheep were used as experimental animals, and the original high-immunity serum was prepared by Brucella antigen immunization method. The specific steps are as follows: Brucella lipopolysaccharide was used to immunize sheep over 3 months old, with a dose of 200 μg / head, and injected into the neck muscle. 21 days after the initial immunization, booster immunization was performed again, and the antibody level was tested 14 days later. If it did not meet the requirements, the third and fourth immunizations were performed. After the antibody level reached the requirements, the neck venous blood was collected, and the serum was separated by natural precipitation method, centrifuged at 3000 rpm / min for 10 min, and then filtered and sterilized with a 0.22 μm filter, and the antibacterial preservative Proclin300 (abbreviated as PC 300) was added to make the final concentration 0.05% (V / V), and then packaged and stored at -20℃ for later use.

[0030] Antibody level qualification standard: The collected serum samples are tested using IDEXX's "Brucella Antibody Detection Kit" ELISA kit, and the brucellosis antibody level is determined by the maximum dilution gradient in which the test sample is positive. If the antibody level test result is greater than 120%, it is a qualified original high-immune serum.

[0031] 2. Components of Antibody Dilution Solution The antibody diluent contains the following substances: 0.3% PC 300, 1% BSA, 0.01 M PBS buffer (pH=7.0), and 0.1% Tween-20.

[0032] 3. Preparation of Calibrators Dilute the original Brucella high immune serum to the following concentrations using the above antibody diluent as calibrators 1-6: 0 IU / mL (antibody diluent), 5 IU / mL, 10 IU / mL, 50 IU / mL, 100 IU / mL, 500 IU / mL, 6 bottles in total, stored at 2-8°C.

[0033] 4. Preparation of quality control products Dilute the original Brucella high immune serum to the following concentrations using the above antibody diluent as calibrators 1-2: 0 IU / mL, 200 IU / mL, 2 bottles in total, stored at 2-8°C.

[0034] Example 2 Concentration selection criteria for acridinium ester labeled bovine / sheep Brucella antigens and HRP labeled bovine / sheep Brucella antigens The matrix method was used to mix acridinium ester-labeled bovine / sheep Brucella antigens and HRP-labeled bovine / sheep Brucella antigens at different dilutions, and the ratio with the lowest cost was given priority.

[0035] The acridinium ester-labeled bovine / sheep Brucella antigen was used at different dilutions of 1 / 10, 1 / 50, 1 / 100, 1 / 500, 1 / 1000, 1 / 5000, and 1 / 10000, and the HRP-labeled bovine / sheep Brucella antigen was used at different dilutions of 1 / 10, 1 / 50, 1 / 100, 1 / 500, 1 / 1000, 1 / 5000, and 1 / 10000 for square array method investigation. The two groups of ratios were cross-matched, and it was found that the optimal ratio was 1 / 50 of acridinium ester-labeled bovine / sheep Brucella antigen and 1 / 100 of HRP-labeled bovine / sheep Brucella antigen, so this appropriate ratio was selected.

[0036] Example 3 A detection kit for completely homogeneous determination of Brucella antibodies, the specific steps are as follows: Solution A: 0.5% bovine serum albumin, 0.01M Tris-HCl solution (pH=7.5), 0.3% Tween-20, 8% lysine, 0.05% PC 300, 0.05% ascorbic acid, 2 mg / mL acridinium ester-labeled bovine / sheep Brucella antigen and 1 mg / mL HRP-labeled bovine / sheep Brucella antigen.

[0037] Solution B: 50 mmol / L hydrogen peroxide and 0.05% PC 300.

[0038] Calibrators: Calibrator 1 (Concentration: 0 IU / mL, antibody diluent only), Calibrator 2 (Concentration: 5 IU / mL), Calibrator 3 (Concentration: 10 IU / mL), Calibrator 4 (Concentration: 50 IU / mL), Calibrator 5 (Concentration: 100 IU / mL), Calibrator 6 (Concentration: 500 IU / mL).

[0039] Quality control products: Quality control product 1 (concentration: 0 IU / mL, antibody diluent only, judgment: negative), quality control product 2 (concentration: 200 IU / mL, judgment: positive).

[0040] The semi-finished product of the test kit is prepared according to the above formula, and after being verified as qualified, it is assembled into a Brucella antibody detection kit.

[0041] Example 4 A detection kit for completely homogeneous determination of Brucella antibodies, the specific steps are as follows: Solution A: 0.5% bovine serum albumin, 0.1M Tris-HCl solution (pH=7.5), 0.3% Tween-20, 0.05% PC 300, 2 mg / mL acridinium ester-labeled bovine / sheep Brucella antigen, and 1 mg / mL HRP-labeled bovine / sheep Brucella antigen.

[0042] Solution B: 50 mmol / L hydrogen peroxide and 0.1% PC 300.

[0043] Calibrators: Calibrator 1 (Concentration: 0 IU / mL, antibody diluent only), Calibrator 2 (Concentration: 5 IU / mL), Calibrator 3 (Concentration: 10 IU / mL), Calibrator 4 (Concentration: 50 IU / mL), Calibrator 5 (Concentration: 100 IU / mL), Calibrator 6 (Concentration: 500 IU / mL).

[0044] Quality control products: Quality control product 1 (concentration: 0 IU / mL, antibody diluent only, judgment: negative), quality control product 2 (concentration: 200 IU / mL, judgment: positive).

[0045] The semi-finished product of the test kit is prepared according to the above formula, and after being verified as qualified, it is assembled into a Brucella antibody detection kit.

[0046] Example 5 A detection kit for completely homogeneous determination of Brucella antibodies, the specific steps are as follows: Solution A: 0.5% bovine serum albumin, 0.05 M Tris-HCl solution (pH=7.5), 0.3% Tween-20, 0.05% PC 300, 2 mg / mL acridinium ester-labeled bovine / sheep Brucella antigen, and 1 mg / mL HRP-labeled bovine / sheep Brucella antigen.

[0047] Solution B: 50 mmol / L hydrogen peroxide and 0.1% PC 300.

[0048] Calibrators: Calibrator 1 (Concentration: 0 IU / mL, antibody diluent only), Calibrator 2 (Concentration: 5 IU / mL), Calibrator 3 (Concentration: 10 IU / mL), Calibrator 4 (Concentration: 50 IU / mL), Calibrator 5 (Concentration: 100 IU / mL), Calibrator 6 (Concentration: 500 IU / mL).

[0049] Quality control products: Quality control product 1 (concentration: 0 IU / mL, antibody diluent only, judgment: negative), quality control product 2 (concentration: 200 IU / mL, judgment: positive).

[0050] The semi-finished product of the test kit is prepared according to the above formula, and after being verified as qualified, it is assembled into a Brucella antibody detection kit.

[0051] Example 6 A detection kit for completely homogeneous determination of Brucella antibodies, the specific steps are as follows: Solution A: 0.5% bovine serum albumin, 0.01 M Tris-HCl solution (pH=7.5), 0.3% Tween-20, 0.05% PC 300, 2 mg / mL acridinium ester-labeled bovine / sheep Brucella antigen, and 1 mg / mL HRP-labeled bovine / sheep Brucella antigen.

[0052] Solution B: 50 mmol / L hydrogen peroxide and 0.1% PC 150.

[0053] Calibrators: Calibrator 1 (Concentration: 0 IU / mL, antibody diluent only), Calibrator 2 (Concentration: 5 IU / mL), Calibrator 3 (Concentration: 10 IU / mL), Calibrator 4 (Concentration: 50 IU / mL), Calibrator 5 (Concentration: 100 IU / mL), Calibrator 6 (Concentration: 500 IU / mL).

[0054] Quality control products: Quality control product 1 (concentration: 0 IU / mL, antibody diluent only, judgment: negative), quality control product 2 (concentration: 200 IU / mL, judgment: positive).

[0055] The semi-finished product of the test kit is prepared according to the above formula, and after being verified as qualified, it is assembled into a Brucella antibody detection kit.

[0056] Example 7 Taking the fully automatic homogeneous chemiluminometer as an example, this embodiment detects the Brucella antibody detection kit described in Example 3. A one-step analysis method is adopted, that is, 3 μL of sample (sample solution to be tested / calibrator of Example 1) and 9 μL of A solution are added, incubated at 37°C for 10 min, 15 μL of B solution is added, and the luminescence intensity is immediately detected continuously for a period of time (1~3s) after mixing, and the peak area is calculated by the instrument. After the measurement, the Brucella antibody concentration of the calibrator is used as the y-coordinate and the peak area is used as the x-coordinate to make a calibration curve (such as Figure 1 The concentration of Brucella antibodies in the sample was calculated based on the calibration curve.

[0057] When the kit of the present invention is used for detection, the incubation time can be adjusted to 5 to 30 minutes according to actual detection needs.

[0058] The specific steps are as follows: ① Reagent loading: Turn on the instrument, click to enter the reagent page, then click "Reagent Location-Reagent Loading" and use a barcode scanner to identify the QR code on the reagent bottle. The reagent information will pop up on the page. Check that it is correct and click "OK" to import the set program into the instrument.

[0059] ②Calibration: Click to enter the calibration page, first click "Calibrator", place the calibrator in the sample position in order, click "Sample Position-Sample Quantity-Confirm", then click "Start", wait for the calibration curve to be generated, R 2 ≥0.99, the instrument will automatically pop up "OK" and the calibration is completed. One calibration curve can be used for 7 days.

[0060] ③Quality Control: Click to enter the quality control page, first click "Quality Control Products", place the quality control products in the sample position in order, click "Sample Position-Sample Quantity-OK", and then click "Start", wait for the test results. If the test value is within the reference range, the instrument will automatically pop up "OK" and the quality control is completed.

[0061] ④Test: Click to enter the test page, first click "Sample", place the samples to be tested in the sample position in order, click "Sample Position-Sample Quantity-Confirm", then click "Start", and wait for the test results.

[0062] ⑤Result: After the test is completed, the instrument automatically displays the test value and judgment result, i.e. negative or positive, in the result column according to the judgment interval set in the program.

[0063] Example 8 This example selects the Brucella antibody detection kit with the best combination for characteristic analysis, namely the Brucella antibody detection kit described in Example 3.

[0064] 1. Correlation analysis Brucella national standard positive serum (China Veterinary Drug Administration) was diluted in series, numbered L1 to L10, and tested by the method. The test results are shown in Table 1. The correlation regression analysis between the known concentration and the measured concentration is shown in Table 1. Figure 2 shown.

[0065] Table 1 Serial dilution test results The results in Table 1 show that there is a certain ± deviation in the results of extremely low concentration samples, while there is no deviation in the results of medium and high concentration samples. Figure 2 The results show that the correlation coefficient between the known concentration and the measured concentration is r=0.9999, which is greater than 0.9900. The above results show that the reagent has good accuracy and specificity.

[0066] 2. Minimum detection limit The results in Table 1 show that the maximum serum dilution concentration for positive detection is between 1.56-0.78 IU / mL, that is, sample number L3-L2. According to the calibration curve, the minimum detection limit corresponds to a concentration of 1 IU / mL.

[0067] 3. Compliance rate detection This method and ELISA were used to test clinical sera of cattle and sheep, including 51 samples of cattle sera (numbered N1-N51) and 22 samples of sheep sera (numbered Y1-Y22). The test results are shown in Table 2: For cattle sera, ELISA and chemiluminescence detected 34 negative samples, with a compliance rate of 100% (34 / 34); ELISA detected 17 positive samples, and chemiluminescence detected 16 positive samples, with a compliance rate of 94% (16 / 17). For sheep sera, ELISA and chemiluminescence detected 2 negative samples, with a compliance rate of 100% (2 / 2); ELISA detected 20 positive samples, and chemiluminescence detected 19 positive samples, with a compliance rate of 95% (19 / 20).

[0068] Table 2 Compliance rate detection The above-mentioned embodiments only express various implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the patent of the present invention. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.

Claims

1. A detection kit for completely homogeneously measuring Brucella antibodies, characterized in that, Including solution A, solution B, calibration products and quality control products.

2. The detection kit according to claim 1, characterized in that The A liquid comprises Brucella antigens labeled with acridinium ester and Brucella antigens labeled with horseradish peroxidase.

3. The detection kit according to claim 2, characterized in that The Brucella antigens are derived from cattle or sheep.

4. The detection kit according to claim 1, characterized in that The A solution also includes one or more of phosphate buffer, Tris-HCl solution, arginine, bovine serum albumin, sodium thiosulfate, trehalose, sucrose, mannitol, disodium ethylenediaminetetraacetic acid, PEG 20000, Tween-20, EC oxidase, enzyme stabilizer, glycerol, ascorbic acid, uric acid, tea polyphenols, glutathione, thioredoxin, lysine, PC 300, and PC 150.

5. The detection kit according to claim 1, characterized in that The B solution includes one or more of p-hydroxycinnamic acid, hydrogen peroxide, urea peroxide, and PC 300.

6. The detection kit according to claim 1, characterized in that The calibrator is a Brucella high immunity serum dilution, and the concentration of the Brucella high immunity serum dilution is 0~500 IU / mL.

7. The detection kit according to claim 1, characterized in that The quality control product is Brucella high immunity serum dilution, and the concentration of the Brucella high immunity serum dilution is 0~200 IU / mL.

8. The detection kit according to claim 1, characterized in that The volume ratio of liquid A to liquid B is (0.6~1):

1.

9. Use of the detection kit according to any one of claims 1 to 8 in detecting Brucella antibodies for non-disease diagnosis purposes.

Citation Information

Patent Citations

  • Detection kit and detection method for complete homogeneous phase determination of adiponectin

    CN109613232A

  • Tubular chemiluminiscence detection kit for brucella antibody and application of tubular chemiluminiscence detection kit

    CN118362720A